Amazing

[Guest guest]

I just watched the video approx. 30 mins. ago. I asked myself if I

could cure disease during the video and the middle of my hands

started pulsating in their center and thumbs began to tingle. I asked

if I could cure myself and my hands began pulsate and tingle again

and an incredible heat began in my Dan Tien (1 inch below my navel)

in the front and back. Tears started rolling down my cheeks because

it was a knowing I had for so long but had doubted so strongly...it

is truly amazing.

I finished watching the video and began the practice. I realized that

not only did my hands respond when I asked " can I cure my eczema? "

the same process hanppened when I asked " can I cure my doubt? " again,

involuntarily my hands began to pulsate and heat up.

In fact, when I asked questions and commanded cures I could feel

different parts of my energy system shifting and changing and opening

up. Energy started coming through the middle of my feet as well and

up into my legs. I felt shifts in my heart around the top of my head

in my kidney area...an intense heat in my kidney and Dan Tien area.

I'm already grateful and blown away. I don't have any proof that

anything is happening or happnened yet only the knowing in my heart.

I could totally utilize this as a spiritual practice for so many

other maladies (as was stated in the video).

Or, I could be totally off.

Amazing. Thanks for letting me share.

Victor

[Guest guest]

I typically would use additional treatments, perhaps two cycles (eight doses) of

standard 375 mg/m2.

Rick Furman, MD

>

> Dr. Furman - are we to understand that if we attempt to control AIHA with

> Rituxan, the dose might need to be significantly more that the 375/m2? Dr.

> O'Brien had been working on greater doses, I believe. Would it be worth

> going for say, 750/m2 if your objective is AIHA?

>

>

> In a message dated 11/8/2009 9:25:18 A.M. Eastern Standard Time,

> rrfurman@... writes:

>

>

>

>

> Carol,

> One problem with using rituximab as a treatment for CLL, AIHA, or ITP is

> that we just do not know the correct dose. In AIHA, the pathologic

> antibodies are made by normal B cells, not the CLL cells, almost all of the

time.

> The thought is that by eliminating enough of the B cells making antibodies,

> you can decrease the antibody production. With CLL patients, it is

> possible that before any of the normal B cells are killed, you have to

eliminate

> many of the CLL cells. Because of the shear number of them present, they

> are going to end up being the target of the rituximab. This keeps them from

> reaching the normal B cells making the antibodies.

> When we dose drugs, we target a concentration, which is not dependent upon

> the number of targets present. But with antibodies, concentration is not

> important. What is important is the number of targets to bind. For CLL,

> with the huge number of cells present, the amount of antibody needed is

> probably much more. This is true, even with CLL cells expressing less CD20

on

> them.

> Rick Furman, MD

>